Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.

T, Heise; L, Nosek; C, Roepstorff; S, Chenji; O, Klein; H, Haahr

doi:10.1007/s13300-014-0070-2

Public

Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.

Shared by NobleBlocks on Jun 3, 2014 • 12:00 AM UTC

Authors:

Heise T

Nosek L

Roepstorff C

Abstract

<h4>Introduction/aim</h4>Insulin degludec/insulin aspart (IDegAsp) is a soluble co-formulation of long-acting and short-acting insulin analogs. The primary objective of this study was to investigate the pharmacodynamic response of once-daily IDegAsp dosing in patients with type 1 diabetes. Pharmacok...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!